Yuan-Yuan Chen

Yuan-Yuan Chen

Auto-generated profile, based on publicly available information

Yuan-Yuan Chen

Zhongnan Hospital of Wuhan University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2020 in medRxiv
Verified
Preprint
Open access
PDF file
HZHong-Yan Zhang
Hong-Yan Zhang
LWLin-Wei Wang
Lin-Wei Wang
YCYuan-Yuan Chen
Yuan-Yuan Chen
XSXiaokun Shen
Xiaokun Shen
QWQun Wang
Qun Wang
CXCong-Hua Xie
Cong-Hua Xie
Background: At present, there is a global pandemic of coronavirus disease 2019 (COVID-19) pneumonia. For COVID-19 patients, cancer is a coexisting disease that should not be Here, we conducted a multicenter retrospective study to show the clinical information and outcomes of cancer patients infected with COVID-19. Measurements: Medical records of COVID-19 patients with cancer admitted to hospitals from Jan 5, 2020 to Feb 18, 2020 were collected. Results: Of the 67 patients (median age: 66 years), the median age of patients with severe illness was older than that of patients with mild symptoms ( P <0.001). The proportion of severe patients had co-morbidities was higher than patients with mild disease ( P =0.004). During the treatment of COVID-19 pneumonia, tumor progression and recurrence was not observed for those patients still at the anticancer treatment phase. Lymphocytopenia was the main laboratory finding accompanying increased C-reactive protein and procalcitonin in cancer patients, especially in severe cases. By Mar 10, 2020, 18 (26.9%) patients died from COVID-19. The median age of survivors was younger than that of deaths ( P =0.014). Lung cancer (n=15, 22.4%) was the most common cancer type and accounted for the highest proportion COVID-19 resulted deaths (33.3%, 5/15). We observed a tendency that patients at the follow-up phase had a better prognosis than that at anticancer treatment phase ( P =0.095). Conclusion: This study showed COVID-19 patients with cancer seem to have a higher proportion of severe cases and poorer prognosis. We should pay more intensive attentions to cancer patients infected with COVID-19.